COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY
Ph.D
Saved in:
Main Author: | TEO WAN CHING JOCELYN |
---|---|
Other Authors: | INTEGRATIVE SCIENCES & ENGINEERING PROG |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/190512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
by: Guo, Ke, et al.
Published: (2021) -
Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
by: Guo, K., et al.
Published: (2014) -
Production of monoclonal antibodies against a leukocyte surface molecule M6 and their use for characterization of M6 molecule / Ponrut Phumpae
by: Ponrut Phunpae
Published: (2014) -
EVALUATION OF CELLULAR RESPONSE, RESISTANCE AND COMBINATORIAL THERAPY WITH VINCRISTINE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
by: KOH SHIMIN, GRACE
Published: (2020) -
STRATEGIES FOR IMPROVEMENT IN MONOCLONAL ANTIBODY PRODUCTION
by: YAP PENG KANG
Published: (2019)